Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease

BACKGROUND: Patients with peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD) are more likely to receive long-term therapy with proton pump inhibitors (PPIs). This study aimed to investigate the risk of osteoporotic fractures in PPI users compared to histamine-2 receptor antagonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Joo-Hyun, Lee, Jessie, Yu, Su-Yeon, Jung, Jin-Hyung, Han, Kyungdo, Kim, Do-Hoon, Rhee, Jinnie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565339/
https://www.ncbi.nlm.nih.gov/pubmed/33059626
http://dx.doi.org/10.1186/s12877-020-01794-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565339/
https://www.ncbi.nlm.nih.gov/pubmed/33059626
http://dx.doi.org/10.1186/s12877-020-01794-3

Ejemplares similares